The interdisciplinary research team at the School of Medicine will work together to explore the effects of factors like ...

To date, six patients have been successfully enrolled into the trial, Of these, two patients were enrolled at Johns Hopkins University School of Medicine and four at Yale School of Medicine’s ...

Every year, thousands of families sit in hospital rooms hearing words no one wants to hear: "We have done everything we can." ...

A sleep researcher at the Yale School of Medicine offered four tips to "fall back" and adjust sleep schedules with the end of ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

A new study led by Yale School of Medicine's Department of Orthopedics & Rehabilitation unveiled key insights into the knee ...

A new study projects that US funding cuts to global health aid will have a catastrophic effect on pediatric TB, with children ...

According to the senior author of the study, Andrey Zinchuk, MD, associate professor of medicine in Yale School of Medicine’s Section of Pulmonary, Critical Care and Sleep Medicine (Yale-PCCSM), SRLMs ...

The researchers suspected the pathway—known as the social perception pathway—might be functional very early in development.

Clearmind Medicine (CMND) announced the enrollment of the last patient for the first cohort of its Phase I/IIa clinical trial evaluating CMND-100, ...

In a new exhibit, there are old unsterilized knives, wooden canes engraved with graduates’ names, a 1950s-era insulin travel ...